Panobinostat, a histone deacetylase inhibitor, for latent-virus reactivation in HIV-infected patients on suppressive antiretroviral therapy: a phase 1/2, single group, clinical trial-Reference-Cited by-同舟云学术

Panobinostat, a histone deacetylase inhibitor, for latent-virus reactivation in HIV-infected patients on suppressive antiretroviral therapy: a phase 1/2, single group, clinical trial

Published:2014-10 Issue:1 Volume:1 Page:e13-e21
ISSN:2352-3018
Container-title:The Lancet HIV
language:en
Short-container-title:The Lancet HIV

Author:

Rasmussen Thomas A,Tolstrup Martin,Brinkmann Christel R,Olesen Rikke,Erikstrup Christian,Solomon Ajantha,Winckelmann Anni,Palmer Sarah,Dinarello Charles,Buzon Maria,Lichterfeld Mathias,Lewin Sharon R,Østergaard Lars,Søgaard Ole S

Funder

Australian National Health and Medical Research Council

NHMRC Practitioner Fellowship and the Division of AIDS, National Institute of Allergy and Infectious Disease, US National Institutes of Health

Publisher

Elsevier BV

Subject

Virology,Infectious Diseases,Immunology,Epidemiology

Reference32 articles.

1. HIV-1 and T cell dynamics after interruption of highly active antiretroviral therapy (HAART) in patients with a history of sustained viral suppression;Davey;Proc Natl Acad Sci USA,1999

2. Presence of an inducible HIV-1 latent reservoir during highly active antiretroviral therapy;Chun;Proc Natl Acad Sci USA,1997

3. Quantification of latent tissue reservoirs and total body viral load in HIV-1 infection;Chun;Nature,1997

4. Identification of a reservoir for HIV-1 in patients on highly active antiretroviral therapy;Finzi;Science,1997

5. Redefining the viral reservoirs that prevent HIV-1 eradication;Eisele;Immunity,2012

Cited by 533 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Analysis of the effect of HDAC inhibitors on the formation of the HIV reservoir;mBio;2024-09-11

2. Advancing Toward a Human Immunodeficiency Virus Cure;Infectious Disease Clinics of North America;2024-09

3. Viral Factors in Modulation of Host Immune Response: A Route to Novel Antiviral Agents and New Therapeutic Approaches;International Journal of Molecular Sciences;2024-08-29

4. Development of a latency model based on HIV-1 subtype C to study how long terminal repeat genetic variation impacts viral persistence and latency reversal;2024-08-02

5. HIV Persistence, Latency, and Cure Approaches: Where Are We Now?;Viruses;2024-07-19